How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have ...

China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

While many top stocks have risen above the fray during periods of market recovery, others haven't followed that upward trend.

How could Trump's demands that drugmakers lower U.S. prices or face penalties impact pharma and biotech stocks? Seeking Alpha ...

Boryung announced on the 4th that Samsung Bioepis officially launched the bone disease treatment drug "Xbric" in South Korea on the 1st. Xbric is a biosimilar (generic drug for biologics) of the ...

Thank you for inviting Senator Tillis’ office to participate in this listening session. Panelists were asked to address an issue impacting drug affordability and accessibility. I appreciate the ...

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.

Medicare costs are projected to rise by their highest amount in years. Here’s what to expect if you’re on Part B or Part D.

There were 18 clubs in the inaugural season of the Premier Soccer League in 1996, but only four survive, going into the ...

Previously, Mr Trump has complained about the total bilateral trade of $212bn, that India hoped would be a sign of closer ...

Under the agreement, ABC Impact will infuse primary capital for a c.16% minority stake in AC Health. The investment will ...

This podcast was recorded on July 21, 2025. Tim Beyers: Is it time to buy biotech? You're listening to Motley Fool Money.